Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Roland Wolf

Showing results (61-70 of 159) with videos related to

Pageof 16
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 28, 2014
Deletion of 30 murine cytochrome p450 genes results in viable mice with compromised drug metabolismNico Scheer, Lesley A McLaughlin, Anja Rode, et al.
The Biochemical Journal|April 21, 2015
Proteome-wide identification and quantification of S-glutathionylation targets in mouse liverDavid J McGarry, Wenzhang Chen, Probir Chakravarty, et al.
NPJ Systems Biology and Applications|May 15, 2024
Simulating BRAFV600E-MEK-ERK signalling dynamics in response to vertical inhibition treatment strategiesAlice De Carli, Yury Kapelyukh, Jochen Kursawe, et al.
Molecular Pharmacology|October 13, 2011
Modeling human cytochrome P450 2D6 metabolism and drug-drug interaction by a novel panel of knockout and humanized mouse linesNico Scheer, Yury Kapelyukh, Jillian McEwan, et al.
Biochemical Pharmacology|November 14, 2002
Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in manLay Beng Goh, Kevin J Spears, Denggao Yao, et al.
The Journal of Biological Chemistry|December 2, 2004
AMP-activated protein kinase mediates phenobarbital induction of CYP2B gene expression in hepatocytes and a newly derived human hepatoma cell lineFranck Rencurel, Alasdair Stenhouse, Simon A Hawley, et al.
British Journal of Cancer|October 8, 2021
Quantifying ERK activity in response to inhibition of the BRAFV600E-MEK-ERK cascade using mathematical modellingSara J Hamis, Yury Kapelyukh, Aileen McLaren, et al.
Cancer Letters|May 12, 2005
Bioactivation of 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone: evidence for DNA adduct formation mediated by cytochrome P450 enzymes and peroxidasesVolker M Arlt, Colin J Henderson, C Roland Wolf, et al.
Plos One|November 27, 2014
HDAC inhibitors increase NRF2-signaling in tumour cells and blunt the efficacy of co-adminstered cytotoxic agentsMichael McMahon, Kathryn H Campbell, A Kenneth MacLeod, et al.
Journal of Proteome Research|December 6, 2013
A targeted in vivo SILAC approach for quantification of drug metabolism enzymes: regulation by the constitutive androstane receptorA Kenneth Macleod, Tuo Zang, Zoe Riches, et al.
Pageof 16

Showing results (61-70 of 159) with videos related to

Sort By:
Pageof 16
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 28, 2014
Deletion of 30 murine cytochrome p450 genes results in viable mice with compromised drug metabolismNico Scheer, Lesley A McLaughlin, Anja Rode, et al.
The Biochemical Journal|April 21, 2015
Proteome-wide identification and quantification of S-glutathionylation targets in mouse liverDavid J McGarry, Wenzhang Chen, Probir Chakravarty, et al.
NPJ Systems Biology and Applications|May 15, 2024
Simulating BRAFV600E-MEK-ERK signalling dynamics in response to vertical inhibition treatment strategiesAlice De Carli, Yury Kapelyukh, Jochen Kursawe, et al.
Molecular Pharmacology|October 13, 2011
Modeling human cytochrome P450 2D6 metabolism and drug-drug interaction by a novel panel of knockout and humanized mouse linesNico Scheer, Yury Kapelyukh, Jillian McEwan, et al.
Biochemical Pharmacology|November 14, 2002
Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in manLay Beng Goh, Kevin J Spears, Denggao Yao, et al.
The Journal of Biological Chemistry|December 2, 2004
AMP-activated protein kinase mediates phenobarbital induction of CYP2B gene expression in hepatocytes and a newly derived human hepatoma cell lineFranck Rencurel, Alasdair Stenhouse, Simon A Hawley, et al.
British Journal of Cancer|October 8, 2021
Quantifying ERK activity in response to inhibition of the BRAFV600E-MEK-ERK cascade using mathematical modellingSara J Hamis, Yury Kapelyukh, Aileen McLaren, et al.
Cancer Letters|May 12, 2005
Bioactivation of 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone: evidence for DNA adduct formation mediated by cytochrome P450 enzymes and peroxidasesVolker M Arlt, Colin J Henderson, C Roland Wolf, et al.
Plos One|November 27, 2014
HDAC inhibitors increase NRF2-signaling in tumour cells and blunt the efficacy of co-adminstered cytotoxic agentsMichael McMahon, Kathryn H Campbell, A Kenneth MacLeod, et al.
Journal of Proteome Research|December 6, 2013
A targeted in vivo SILAC approach for quantification of drug metabolism enzymes: regulation by the constitutive androstane receptorA Kenneth Macleod, Tuo Zang, Zoe Riches, et al.
Pageof 16